Parallel Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Parallel Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-60	Closed	-$2K	–	3393
2021 Q2	$2K	Buy	+60	New	+$1.18K	﹤0.01%	2661
2020 Q4	–	Sell	-137	Closed	-$2K	–	2803
2020 Q3	$2K	Hold	137	–	–	﹤0.01%	2384
2020 Q2	$2K	Sell	137 -652	-83%	-$9.83K	﹤0.01%	2268
2020 Q1	$7K	Buy	+789	New	+$6.46K	﹤0.01%	1805

Parallel Advisors's TBIO Position: Q3 2021 in Review

Parallel Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 60 shares — an estimated $2K sold.

Parallel Advisors first reported a position in TBIO in Q1 2020 and held it in 4 quarters. The position peaked at $7K in Q1 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Parallel Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Parallel Advisors sold 60 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $2K.
Parallel Advisors first reported a position in Translate Bio, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
Parallel Advisors's Translate Bio, Inc. Common Stock position peaked at $7K in Q1 2020.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.